Table 2 Clinical characteristics of study subjects with MCI
Mild cognitive impairment (n=38) | Normal cognitive function (n=106) | P-value | |
---|---|---|---|
Age (years) | 74±6 | 67±6 | <0.001 |
Sex (male/female) | 17/21 | 32/74 | 0.104 |
Body mass index (kg/m2) | 23±3 | 23±3 | 0.818 |
Hypnotic treatment | 5 | 4 | 0.040 |
Type II diabetes (n) | 7 | 9 | 0.095 |
Brachial-ankle pulse wave velocity (cm s−1) | 1808±380 | 1595±285 | 0.001 |
Systolic BP | |||
Clinic (mm Hg) | 139±19 | 136±20 | 0.358 |
24-h (mm Hg) | 135±15 | 128±14 | 0.019 |
Awake (mm Hg) | 138±14 | 131±15 | 0.020 |
Sleeping (mm Hg) | 125±23 | 116±15 | 0.008 |
Nocturnal BP change (%) | −10±12 | −12±8 | 0.291 |
Diastolic BP | |||
Clinic (mm Hg) | 76±11 | 77±10 | 0.537 |
24-h (mm Hg) | 76±6 | 77±7 | 0.888 |
Awake (mm Hg) | 78±6 | 79±7 | 0.774 |
Sleeping (mm Hg) | 70±10 | 68±8 | 0.193 |
Nocturnal BP change (%) | −10±12 | −13±9 | 0.127 |
Apolipoprotein E ɛ4 allele (n) | 14 | 20 | 0.025 |